GlassScriptPhysician profile
Robert T Grissom
NPI 1457388639
$2,933.93
in general payments reported to CMS, 2019-2025
34 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $586 · 2020: $140 · 2021: $484 · 2022: $594 · 2023: $1,102 · 2024: $28.26.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,130.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,130.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $579.25 | 2019-2024 | Xtandi, Myrbetriq |
| Sumitomo Pharma America, INC. | $407.15 | 2023 | Gemtesa |
| Janssen Biotech, INC. | $237.09 | 2019-2023 | |
| Dendreon Pharmaceuticals LLC | $232.58 | 2019-2023 | Provenge |
| Abbvie INC. | $128.95 | 2019-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $106.62 | 2019-2022 | |
| Blue Earth Diagnostics | $103.53 | 2019-2022 | |
| Antares Pharma, INC. | $93.79 | 2019-2022 | |
| 180 Medical, INC. | $92.09 | 2019-2023 | Cure Catheter |
| C. R. Bard, INC. & Subsidiaries | $84.29 | 2023 | Bard Urinary Drainage Bag |
| Procept Biorobotics Corporation | $83.97 | 2021-2023 | Aquabeam Robotic System |
| Endo Pharmaceuticals INC. | $83.42 | 2019-2023 | Xiaflex, Aveed |
| Progenics Pharmaceuticals, INC. | $70.15 | 2022-2023 | Pylarify |
| Hollister Incorporated | $64.10 | 2021-2023 | Infyna Chic |
| Urovant Sciences INC | $51.69 | 2021-2022 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Accord Healthcare, INC. | $50.51 | 2023 | |
| Teleflex LLC | $50.43 | 2022 | |
| Myriad Genetic Laboratories, INC. | $45.33 | 2023 | Prolaris |
| Tolmar Pharmaceuticals, INC. | $39.80 | 2019-2020 | |
| Rochester Medical Corporation | $37.72 | 2019-2020 | |
| Allergan, INC. | $36.12 | 2019 | |
| Neotract INC. | $26.52 | 2019 | |
| Pfizer INC. | $25.83 | 2019 | |
| Acerus Pharmaceuticals Corporation | $25.42 | 2021 | |
| Clarus Therapeutics INC. | $25.36 | 2021 | |
| Merck Sharp & Dohme LLC | $21.38 | 2022 | |
| Agiliti Surgical, INC. | $19.65 | 2019 | |
| Ambu INC. | $18.53 | 2022 | |
| Tolmar, INC. | $18.47 | 2023 | |
| Dornier Medtech America, INC | $17.84 | 2019 | |
| Axonics, INC. | $16.16 | 2022 | |
| Myovant Sciences INC. | $14.75 | 2021 | |
| Urogen Pharma, INC. | $13.62 | 2021 | |
| Ethicon US, LLC | $11.82 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Grissom listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.